Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Implementing Shared Decision Making in Hemophilia Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
    Improving the Vaccination Environment to Prevent Respiratory Infectious Diseases in Older Adults and High-Risk Individuals
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Quality Improvement Vaccines Japan
    Improving Shared Decision Making in Hemophilia: Visiting Professorship Program - 2026, Semester 2
    Release Date:
    Partner: Hemostasis & Thrombosis Research Society (HTRS)
    Review Process: Expert Review Panel
    Education Rare Disease USA
    Development of Healthcare Professionals with Advanced Expertise in Preventive Strategies in Pediatric Infectious Diseases
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Vaccines Japan
    Current and Emerging Therapies: The future of Recurrent or Metastatic (r/m) Cervical Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    The Role of RSV in Functional Decline and Healthcare Dependency in Hospitalized Adults
    Release Date:
    Review Process: Expert Review Panel
    Research Vaccines Italy
    Improving the Quality and Standardization of Pneumococcal Diagnostic Pathways in Pediatric and Adult Populations
    Release Date:
    Review Process: Expert Review Panel
    Research Vaccines Italy
    Interventional Research Studies of Brentuximab Vedotin-Based Novel Combinations in AITL and PTCL-NOS
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology USA
    Optimizing Early Biomarker Testing to Guide Clinical Decision-Making in Colorectal Cancer Across Latin America
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Argentina, Brazil, Chile, Colombia, Mexico, Peru
    Optimizing Maternal RSV Immunization Delivery: A Systems-Based QI Initiative to Improve Uptake, Equity, and Newborn Outcomes
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Vaccines USA
    Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)
    Release Date:
    Partner: Astellas
    Review Process: Expert Review Panel
    Education Oncology All
    Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer Care: Visiting Professorship
    Release Date:
    Partner: Prostate Cancer Foundation
    Review Process: Expert Review Panel
    Education Oncology USA
    Improving Venous Thromboembolism (VTE) Diagnosis and Treatment with Primary Care Settings- A Quality Improvement Project
    Release Date:
    Partner: American Academy of Family Physicians
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Growth Hormone Research
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease USA
    Efforts for early detection of atrial fibrillation and cardioembolic stroke prevention
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine Japan
    Preventing cardiovascular diseases such as venous thromboembolism in cancer patients by raising awareness and promoting medical
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Patient Registries In ATTR-CM
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease Japan
    Optimizing Menopausal Symptom Management in Canada
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Internal Medicine Canada
    Optimizing Menopausal Symptom Management in Canada
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Internal Medicine Canada
    Gene and Anti-TFPI Therapies in Hemophilia
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease All
    Implementing Updated Pneumococcal Immunization Recommendations in Adults
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Vaccines USA
    Biomarker Testing / Lung Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Employment support / Lung Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Cachexia in Cancer – Educational Needs Assessment (USA, Canada, Japan, Italy, UK, Spain, Germany, France)
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Canada, France, Germany, Italy, Japan, Spain, USA, United Kingdom
    Addressing Knowledge Gaps in the Care of Patients with HR-positive/HER2-negative Advanced Breast Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Hemophilia Research in Africa-Middle East, Asia Pacific, China and Latin America
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease All
    Rheumatic diseases such as SLE, SS, SSc, vasculitis syndrome
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Japan
    Optimal treatment and management of Rheumatoid Arthritis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Japan
    Education relating to Etiology, diagnosis, treatment and, management of Spondyloarthritis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Japan
    Inflammation ASPIRE Rheumatology: Europe (except Germany), Israel, Turkey, Russia, Australia, New Zealand, Japan and South Korea
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
    Inflammation ASPIRE Ulcerative Colitis:Europe (except Germany), Israel, Turkey,Russia,Australia,New Zealand, Japan, South Korea
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
    Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease All
    Hemophilia: Improve general knowledge level of gene therapy
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    Providing Enhanced Medical Support for Patients with Primary Immunodeficiency (PI) Disorders
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Serotyping of Streptococcus pneumoniae
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Artificial Intelligence/Machine Learning Research in Hemophilia
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease USA
    Education of Healthcare Professionals to Provide Appropriate Medical Care for IBD Patients
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Japan
    Enhancing awareness and well understanding of the management in hypothalamic pituitary dysfunction, growth disorders
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    Long-acting Growth Hormone Research
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    COVID-19: Continuity in Care for Patients with Metastatic Breast Cancer Grant Support Program (United States and Europe)
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology All
    2020 Osteoarthritis and Osteoarthritis Pain- Virtual Learning
    Release Date:
    Partner:

    Lilly

    Review Process: Pfizer Internal
    Education Internal Medicine All
    NASH – Future of Non-invasive Diagnosis Technologies
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Nurse Navigator
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
    Pfizer-ISID 2020 AFME Grant Challenge (Africa and the Middle East)
    Release Date:
    Partner:

    International Society for Infectious Diseases (ISID)

    Review Process: Expert Review Panel
    Quality Improvement Hospital All
    Advances in Oncology Therapy in Renal Cell Carcinoma
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Increasing Awareness of Nuclear Scintigraphy in Cardiac Amyloidosis
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    Pfizer and RCNi – Providing Access to Learning Resources for Nurses in the APAC/China Region
    Release Date:
    Partner:

    RCNi (subsidiary of the Royal College of Nursing)

    Review Process: Pfizer Internal
    Education Internal Medicine Hong Kong, India, Indonesia, Malaysia, Pakistan, Philippines, Singapore, Taiwan, Thailand, Vietnam
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease Argentina, Brazil, Chile, Colombia
    Vaccine Preventable Diseases – COVID-19 (closed early)
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines All
    Phase I/II Clinical Trials of Axitinib in the Treatment of Melanoma, Hepatocellular Carcinoma and Colorectal Cancer
    Release Date:
    Partner:

    NCCN

    Review Process: Expert Review Panel
    Research Oncology All, USA
    Advances in Moderate-to-Severe Atopic Dermatitis for Dermatologists
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Incorporating Biosimilar Treatment Options in Solid Tumor Education Programs
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    NSCLC – Current Practice Considerations
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Mexico, Monaco, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, USA, United Kingdom
    Gram Negatives Pathogens & Antimicrobial Resistance: Local Data Generation in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Research Hospital Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, Guatemala, Honduras, Mexico, Panama, Peru, Uruguay
    Addressing Health Disparities in Inflammatory Bowel Disease
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology USA
    Enduring SpA Programs
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All
    Atopic Dermatitis Patient Education
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Knowledge Gaps in Updated Pneumococcal Immunization Recommendations
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Prostate Cancer Disparities Project
    Release Date:
    Partner:

    American Cancer Society

    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    Telehealth Solutions in Rheumatoid Arthritis for Improving Education and Patient Care (Emerging Markets)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All
    Telehealth Solutions in Atopic Dermatitis for Improving Education and Patient Care (Emerging Markets)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All